Is alpha-hydroxybutyrate an early biomarker of insulin resistance and glucose intolerance in a nondiabetic population?
alpha-hydroxybutyrate is an early marker for both insulin resistance and impaired glucose regulation. The underlying biochemical mechanisms may involve increased lipid oxidation and oxidative stress.
There are dramatic differences among patients. Such differences need to be considered in planning treatments.